Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
Essentially, this design emulated a randomised controlled trial, in which participants on a background therapy with one of the drug classes of interest (GLP-1 receptor agonists or SGLT-2 inhibitors) are randomised to either continue the background drug or add on the other drug of interest (SGLT-2 inhibitor or GLP-1 receptor agonist, respectively)
What is GLP-1 and Why Does it Matter for Weight Loss
I think over time, we will without a shadow of doubt recognize that there are real cost benefits to the coverage of these medications. With reports from Carly Weeks, The Canadian Press and Reuters
10.1038/ncomms7498 85
US$ 21.01
US$ 21.60
US$ 23.54
